Correlation between the Serum Platelet-Derived Growth Factor, Angiopoietin-1, and Severity of Coronary Heart Disease

Table 1

Baseline characteristics of all the study subjects.

Variables	Control (n = 29)	ACS groups
		Total (n = 81)	UAP groups (n = 20)	AMI groups (n = 61)
Age (years)	59.62 ± 9.59	60.84 ± 0.78	62.2 ± 8.46	60.39 ± 11.46
Female, [n (％)]	16 (55.17%)	64 (79.01%)	14 (70.00%)	50 (81.96%)
Hypertension, [n (％)]	20 (68.97%)	49 (60.49%)	9 (45%)	40 (65.57%)
Diabetes, [n (％)]	11 (37.93%)	14 (17.28%)	4 (20%)	10 (16.39%)
Smoking, [n (％)]	4 (13.79%)	40 (49.38%)	6 (30%)	34 (55.74%)
BMI (kg/m3)	23.56 ± 2.69	24.86 ± 3.14	23.37 ± 2.57	25.34 ± 3.17
History of medication
Nitrates, [n (％)]	13 (44.83)	47 (58.02)	16 (80.0)	31 (50.82)
Beta blockers, [n (％)]	10 (34.45)	41 (50.62)	9 (45.0)	32 (52.46)
ACEIs/ARBs, [n (％)]	12 (41.38)	33 (40.74)	7 (35.0)	26 (42.62)
CCBs, [n (％)]	9 (31.03)	12 (14.81)	5 (25.0)	7 (11.47)
Aspirin, [n (％)]	29 (100)	81 (100)	20 (100)	61 (100)
Clopidogrel, [n (％)]	16 (55.17)	80 (98.77)	20 (100)	60 (98.36)
SBP (mmHg)	133.45 ± 15.68	128.64 ± 20.52	133.85 ± 17.71	126.93 ± 21.22
DBP (mmHg)	80.03 ± 7.62	78.42 ± 12.49	78.55 ± 9.08	78.38 ± 13.49
FBS (mmol/l)	5.58 ± 1.30	6.83 ± 2.60	5.87 ± 2.12	7.15 ± 2.68
HbA1c (%)	6.58 ± 1.45	6.65 ± 2.16	6.01 ± 0.81	6.86 ± 2.42
TC (mmol/l)	4.57 ± 1.07	4.97 ± 1.33	4.43 ± 1.17	4.52 ± 1.22
LDL-C (mmol/l)	2.71 ± 0.77	2.88 ± 0.94	2.61 ± 0.76	2.97 ± 0.98
HDL-C (mmol/l)	1.21 ± 0.27	1.08 ± 0.65	1.12 ± 0.34	1.06 ± 0.33
TG (mmol/l)	1.78 ± 1.03	1.69 ± 0.1.22	1.46 ± 0.71	1.76 ± 1.35
SUA (μmol/l)	319.87 ± 80.32	318.82 ± 83.18	356.33 ± 84.69	338.47 ± 99.07
Scr (μmol/l)	74.32 ± 17.78	76.78 ± 20.48	72.47 ± 17.87	78.19 ± 21.21
eGFR	92.28 ± 22.11	96.26 ± 24.59	98.91 ± 23.99	95.39 ± 24.91
PLT	188.89 ± 52.67	186.15 ± 62.85	198.9 ± 59.95	181.97 ± 63.69

, control vs. other groups; , UAP groups vs. other groups. Data are given as mean ± SD, number (%). ACS, acute coronary syndrome; UAP, unstable angina pectoris; AMI, acute myocardial infarction; BMI, body mass index; ACEIs, angiotensin-converting enzyme inhibitors; ARBs, angiotensin receptor blockers; CCBs, calcium channel blockers; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBS, fasting blood glucose; HbA1c, glycosylated haemoglobin; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; TG, triglyceride; SUA, serum uric acid; Scr, serum creatinine; eGFR, estimated glomerular filtration rate; PLT, platelet count.